规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Allopurinol sodium is a highly effective and orally active inhibitor of xanthine oxidase, with an IC50 ranging from 0.2 to 50 μM. It is commonly utilized in the study of hyperuricemia and gout. Beyond its primary application, Allopurinol sodium is known to decrease the expression of HIF-1α and HIF-2α proteins, exhibiting potential in reducing hypoxia-induced factors. Additionally, it has demonstrated antidepressant, anti-nociceptive, and anti-leishmanial activities[1].[2].[3].[4].[5]. |
体内研究 | In vivo, when administered orally at a dose of 39 mg/kg daily for 21 consecutive days, Allopurinol sodium shows antidepressant activity in mice[3]. Furthermore, administered intraperitoneally at doses ranging from 10 to 400 mg/kg, it induces significant anti-nociceptive effects in mice[4]. |
体外研究 | In cell-based studies, Allopurinol sodium at concentrations of 0, 10, 100, and 1000 µg/ml over 17 hours significantly reduces the expression of HIF-1α and HIF-2α in HFF (human fibroblasts) and HUVEC (human umbilical vein endothelial cells) cells. Over a 24-hour period at the same concentrations, it also reduces angiogenesis traits in HUVEC cells[5]. |
Concentration | Treated Time | Description | References | |
Mouse aortic endothelial cells | 100 μmol/L | 4 hours | To investigate the effect of allopurinol on MP-mediated oxidative stress in endothelial cells, results showed that allopurinol had no significant effect on MP-mediated ROS production. | J Am Heart Assoc. 2012 Jun;1(3):e001842. |
THP-1 human myeloid leukemia cells | 250 μg/ml | 1 hour pre-treatment | Pre-treatment with allopurinol attenuated XOD activation/UA production and significantly decreased phospho-S2448 mTOR levels while increasing T2446 phosphorylation. | Sci Rep. 2014 Sep 9;4:6307. |
Administration | Dosage | Frequency | Description | References | ||
Mice | Wild-type and AMPD2 knockout mice | Drinking water | 1.1 mM | 30 weeks | Allopurinol significantly reduced plasma and intrahepatic uric acid levels in MSG + IMP-treated mice and attenuated weight gain and features of metabolic syndrome. | Nat Metab. 2021 Sep;3(9):1189-1201 |
Mice | Endotoxin-induced bacterial translocation model | Oral gavage | 50 mg/kg | Once at 48 and 24 hours before | To investigate the effect of allopurinol on endotoxin-induced bacterial translocation. Results showed that allopurinol significantly reduced endotoxin-induced bacterial translocation and mucosal injury. | J Clin Invest. 1989 Jul;84(1):36-42 |
C57BL6/J male mice | Western diet-induced obesity model | Drinking water administration | 125 mg/L | Continued for 16 weeks | XO inhibition significantly attenuated WD-induced increases in plasma uric acid, vascular XO activity and oxidative stress, in concert with reductions in proteinuria. Further, XO inhibition prevented WD-induced increases in aortic EnNaC expression and associated endothelial and subendothelial stiffness. XO inhibition also reduced vascular pro-inflammatory and maladaptive immune responses induced by consumption of a WD. | Metabolism. 2017 Sep;74:32-40 |
C57BL/6 mice | Hyperuricaemia model | Oral | 5 mg/kg | 7 consecutive days | Reduced serum uric acid levels and inhibited liver xanthine oxidase activity | Pharm Biol. 2020 Dec;58(1):944-949 |
Mice | Hypertension model | Intraperitoneal injection | 100 mg/kg | Not specified | Inhibition of xanthine-oxido-reductase prevented blood flow recovery in the ischemic hind-limb of hypertensive mice treated with sodium nitrite | Pflugers Arch. 2012 Dec;464(6):583-92 |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
6.33mL 1.27mL 0.63mL |
31.63mL 6.33mL 3.16mL |
63.26mL 12.65mL 6.33mL |
CAS号 | 17795-21-0 |
分子式 | C5H3N4NaO |
分子量 | 158.09 |
SMILES Code | [O-]C1=C2C(NN=C2)=NC=N1.[Na+] |
MDL No. | MFCD12965022 |
别名 | |
运输 | 蓝冰 |
InChI Key | PTJRZVJXXNYNLN-UHFFFAOYSA-M |
Pubchem ID | 23662349 |
存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry,Store in freezer, under -20°C |
溶解方案 |
H2O: 50 mg/mL(316.27 mM),配合低频超声,并水浴加热至45℃助溶 |